Sysmex Corporation (SSMXF)

Market Cap	10.65B
Revenue (ttm)	3.40B
Net Income (ttm)	358.40M
Shares Out	n/a
EPS (ttm)	0.57
PE Ratio	29.71
Forward PE	n/a
Dividend	0.24 (1.58%)
Ex-Dividend Date	Sep 29, 2025

Volume	227
Average Volume	310
Open	15.80
Previous Close	15.30
Day's Range	15.80 - 15.80
52-Week Range	14.73 - 20.73
Beta	0.81
RSI	42.34
Earnings Date	Aug 6, 2025

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte co...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1968
• Employees: 10,533
• Stock Exchange: OTCMKTS
• Ticker Symbol: SSMXF

Financial Performance

In 2024, Sysmex's revenue was 508.64 billion, an increase of 10.21% compared to the previous year's 461.51 billion. Earnings were 53.67 billion, an increase of 8.12%.

Financial numbers in JPY